Successful treatment of massive acute upper gastrointestinal bleeding in liver failure with activated recombinant factor VII (NovoSeven): A case report [2]

Blood Coagulation and Fibrinolysis

Volumn 16, Issue 5, 2005, Pages 385-387

  Tonkic, Ante ^a,b   Jukic, Ivana ^a   Titlic, Marina ^a,b   Mise, Stjepan ^a,b  

^a UNIVERSITY HOSPITAL SPLIT   (Croatia)

^b UNIVERSITY OF SPLIT   (Croatia)

Author keywords

Activated recombinant factor VII; Acute upper gastrointestinal bleeding; Liver failure; Portal hypertensive gastropathy

Indexed keywords

FRESH FROZEN PLASMA; METHADONE; OCTREOTIDE; PANTOPRAZOLE; PHYTOMENADIONE; PLIBEX; POLIDOCANOL; PROPRANOLOL; RECOMBINANT BLOOD CLOTTING FACTOR 7A; VITAMIN B COMPLEX;

ADULT; CASE REPORT; ENDOSCOPY; FEMALE; HUMAN; LETTER; LIVER FAILURE; PRIORITY JOURNAL; RESUSCITATION; STOMACH DISEASE; UPPER GASTROINTESTINAL BLEEDING;

EID: 22444436249     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mbc.0000172098.04040.da     Document Type: Letter

References (15)

1. Longstreth GF. Epidemiology of hospitalization for acute upper gastrointestinal hemorrhage: a population-based study. Am J Gastroenterol 1995; 90:861-868.
2. Primignani M, Carpinelli L, Preatoni P, Battaglia G, Carta A, Prada A, et al. Natural history of portal hypertensive gastropathy in patients with liver cirrhosis. The New Italian Endoscopic Club for the study and treatment of esophageal varices (NIEC). Gastroenterology 2000; 119:181-187.
3. Triger DR. Portal hypertensive gastropathy. In: Okuda K, Benhamou JP. (editors): Portal hypertension. Clinical and physiological aspects. Tokyo: Springer-Verlag; 1991, pp. 441-452.
4. Sarin SK, Sreenivas DV, Lahoti D, Saraya A. Factors influencing development of portal hypertensive gastropathy in patients with portal hypertension. Gastroenterology 1992; 102:994-999.
5. Triger DR, Hosking SW. The gastric mucosa in portal hypertension. J Hepatol 1989; 8:267-272.
6. Mammen EF. Coagulation abnormalities in liver disease. Hematol Oncol Clin North Am 1992; 6:1247-1257.
7. De Franchis R, Primignani M. Natural history of portal hypertension in patients with cirrhosis. Clin Liver Dis 2001; 5:645-663.
8. Shami VM, Caldwell SH, Hespenheide EE, Arseneau KO, Bickston SJ, Macik BG. Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy. Liver Transpl 2003; 9:138-143.
9. Bosch J, Thabut D, Bendtsen F, D'Amico G, Albillos A, Gonzalez Abraldes J, et al. European Study Group on rFVIIa in UGI Haemorrhage: recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trial. Gastroenterology 2004; 127:1123-1130.
10. Roberts HR, Monroe DM 3rd, Hoffman M. Safety profile of recombinant factor VIIa. Semin Hemat 2004; 41 (suppl 1):101-108.
11. Pavese P, Bonadona A, Beaubien J, Labrecque P, Pernod G, Letoublon C, et al. FVIIa corrects the coagulopathy of fulminant hepatic failure but may be associated with thrombosis: a report of four cases. Can J Anaesth 2005; 52:26-29.
12. Ejlersen E, Melsen T, Ingerslev J, Andreasen RB, Vilstrup H. Recombinant activated factor VII (rFVIIa) acutely normalizes prothrombin time in patients with cirrhosis during bleeding from oesophageal varices. Scand J Gastroenterol 2001; 36:1081-1085.
13. Parameswaran R, Shapiro AD. The use of recombinant factor VIIa in gastrointestinal bleeding. Transfusion Alternatives Transfusion Med 2003; (suppl 5):23-30.
14. Heuer L, Blumenberg D. Recombinant factor VIIa (NovoSeven R). A review of current and possible future indication. Anaesthesist 2002; 51:388-389.
15. Dejgaard A. Update on Novo Nordisk's clinical trial programme on NovoSeven. Blood Coagul Fibrinolysis 2003; 14(suppl 1):39-41.